dren with acute lymphoblastic leukemia. 10 We report the case of a 12-year-old female with FA who underwent BMT following a conditioning regimen comprising Flu (30 mg/ Allogeneic bone marrow transplantation (BMT) is an effective therapy for Fanconi's anemia (FA). However, m 2 × 5 days), ATG (10 mg/kg × 4 days) and CY (10 mg/kg × 2 days) with sustained engraftment and minimortality and transplant-related complications are usually high due to increased sensitivity to the alkylating mal toxicity. agents and radiation commonly used for pre-transplant conditioning. Fludarabine monophosphate is a purine analogue that has been proven effective as a conditionCase report ing agent for chronic lymphocytic leukemia patients. We report a child with FA in leukemic transformation with thrombocytopenia and 20% myeloblasts who A 12-year-old girl with FA transforming to AML was referred for BMT from her HLA-matched MLC nonunderwent successful BMT following conditioning with fludarabine/ATG/cyclophosphamide. The regimen was reactive male cousin. Her sister underwent successful BMT for FA in 1995 at the age of 4 years. On admission, the well tolerated, no transplant-related complications were observed, and engraftment was rapid. The child is patient's WBC was 3.1 × 10 9 /l (9.3% neutrophils), platelets 18 × 10 9 /l, and Hb 7.5 g/dl. Bone marrow aspiration discurrently 10 months post-BMT, in excellent clinical condition with a normal blood count, 100% chimerism closed 20% blasts with myelomonocytic characteristics. Her lymphocytes showed increased chromosome breaks and no sign of graft-versus-host disease (GVHD). We suggest that this fludarabine-based regimen may be both spontaneously and after incubation with diepoxybutane. Liver and kidney function tests were normal. She effective in the conditioning of standard, as well as transforming, FA patients for BMT.
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was conditioned with Flu (30 mg/m 2 × 5 days), ATG (10 mg/kg × 4 days) and CY (10 mg/kg × 2 days). TwentyKeywords: Fanconi's anemia; bone marrow transplantation; fludarabine; toxicity; engraftment four hours following the last dose of chemotherapy she received 4.8 × 10 8 /kg non-manipulated nucleated cells from her HLA-matched cousin followed by G-CSF (5 g/kg) until the day of engraftment. Cyclosporine A was adminisAlthough BMT can eliminate the hematologic manifestrated as GVHD propylaxis. Engraftment was rapid with tations of FA, patients tend to be susceptible to compli-ANC Ͼ0.5 × 10 9 /l on day +12, WBC Ͼ1 × 10 9 /l on day cations associated with the use of cyclophosphamide (CY) +12, platelets Ͼ25 × 10 9 /l and 50 × 10 9 /l on day +18 and in the conditioning regimen. [1] [2] [3] [4] Reduced acute toxicity fol-+25, respectively. Following transplantation, there was a lowing BMT has been associated with reduction of the total transient rise in liver function values, with the bilirubin CY dose to 20 mg/kg. 3, 4 This minimal CY dose has been reaching 109 mmol/l (normal range 2.5-17 mmol/l), alaused in conjunction with irradiation or anti-thymocyte nine aminotransferase 144 U (normal range, 6-53 U), globulin (ATG).
3 Recently fludarabine monophosphate asparate aminotransferase 52 U (normal range 2-60), alka-(Flu) has been used as part of a non-myeloablative preline phosphatase 183 U (normal range 44-130 U) and BMT conditioning regimen facilitating engraftment while gamma GTP 351 U (normal range 10-180 U). Toxicity was sparing the graft-versus-leukemia effect. [5] [6] [7] Flu is a fluorimild, with grade II mucositis, diarrhea and abdominal pain. nated analogue of adenosine arabinoside that has been used
The patient was discharged on day +21 with normal liver with a response rate of up to 50% in low-grade lymphoid and kidney function. She is currently 10 months post-BMT malignancies.
8,9 Some effect has also been observed in chilwith excellent clinical performance (Karnofsky score 100%), normal blood count (WBC 6.0 × 10 9 /l, Hb 13.2 g%, platelets 215 × 10 9 /l) with no sign of GVHD. Cytogenetics and good tolerability.
5,7-9
In addition, omission of 
